A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination

BACKGROUND: Emerging observational evidence suggests a single-dose of human papillomavirus (HPV) vaccine may be protective against vaccine-targeted HPV infection and associated cervical dysplasia. We aimed to demonstrate whether a single dose of quadrivalent HPV (4vHPV) vaccine was immunogenic and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Batmunkh, Tsetsegsaihan, Dalmau, Marguerite T., Munkhsaikhan, Margad-Erdene, Khorolsuren, Tungalagtuya, Namjil, Narantuya, Surenjav, Unursaikhan, Toh, Zheng Quan, Licciardi, Paul V., Russell, Fiona M., Garland, Suzanne M., Mulholland, Kim, von Mollendorf, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254061/
https://www.ncbi.nlm.nih.gov/pubmed/32387009
http://dx.doi.org/10.1016/j.vaccine.2020.04.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254061/
https://www.ncbi.nlm.nih.gov/pubmed/32387009
http://dx.doi.org/10.1016/j.vaccine.2020.04.041

Ejemplares similares